Article ; Online: Immunoexpression of TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers and its correlation with degree of differentiation, tumor staging and prognostic factors in colorectal adenocarcinoma: a retrospective longitudinal study.
Sao Paulo medical journal = Revista paulista de medicina
2019 Volume 137, Issue 1, Page(s) 33–38
Abstract: Background: There are cases of colorectal tumors that, although small, show more aggressive evolution than large tumors. This motivated us to study whether there are any proteins capable of alerting about these changes. The aim here was to correlate the ...
Abstract | Background: There are cases of colorectal tumors that, although small, show more aggressive evolution than large tumors. This motivated us to study whether there are any proteins capable of alerting about these changes. The aim here was to correlate the immunoexpression of the TS, p53, COX2, EGFR, MSH6 and MLH1 biomarkers in tumors in patients with colorectal adenocarcinoma, with the degree of cell differentiation, tumor staging and clinical-pathological prognostic factors. Design and setting: Retrospective observational study at a public tertiary-level hospital. Methods: We analyzed tissue-microarray paraffin blocks of tumor tissues that had been resected from 107 patients. We used Fisher's exact test to study associations between tumor differentiation/staging and the immunoexpression of biomarkers. We also used Kaplan-Meier estimation, the log-rank test and the adjusted Cox regression model to investigate the patients' overall survival (in months) according to biomarkers and disease-free interval. Results: The degree of tumor differentiation and tumor staging were not associated with the biomarkers, except in cases of patients in stages III or IV, in which there was a correlation with MLH1 expression (P=0.021). Patient survival and disease-free interval were not associated with the biomarkers. Conclusion: There were no associations between the degree of tumor differentiation, staging, length of survival or disease-free interval and the immunoexpression of the TS, p53, COX2, EGFR or MSH6 tumor markers. In advanced cases of colorectal adenocarcinoma (stages III and IV), there was a higher percentage of MLH1-negative results. |
---|---|
MeSH term(s) | Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/analysis ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Cyclooxygenase 2/analysis ; DNA-Binding Proteins/analysis ; ErbB Receptors/analysis ; Female ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Longitudinal Studies ; Male ; Middle Aged ; MutL Protein Homolog 1/analysis ; Neoplasm Staging ; Proportional Hazards Models ; Reference Values ; Retrospective Studies ; Thymidylate Synthase/analysis ; Tissue Array Analysis ; Tumor Suppressor Protein p53/analysis ; Young Adult |
Chemical Substances | Biomarkers, Tumor ; DNA-Binding Proteins ; G-T mismatch-binding protein ; MLH1 protein, human ; Tumor Suppressor Protein p53 ; Cyclooxygenase 2 (EC 1.14.99.1) ; Thymidylate Synthase (EC 2.1.1.45) ; EGFR protein, human (EC 2.7.10.1) ; ErbB Receptors (EC 2.7.10.1) ; MutL Protein Homolog 1 (EC 3.6.1.3) |
Language | English |
Publishing date | 2019-05-21 |
Publishing country | Brazil |
Document type | Journal Article ; Observational Study |
ZDB-ID | 1203171-9 |
ISSN | 1806-9460 ; 1516-3180 ; 0035-0362 |
ISSN (online) | 1806-9460 |
ISSN | 1516-3180 ; 0035-0362 |
DOI | 10.1590/1516-3180.2018.0270071218 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 184: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.